Catalyst Wire Dossier Catalyst Wire Dossier

GT20029

· Suzhou Kintor Pharmaceutical Inc
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for GT20029, covering 2024-11-18 to 2024-11-18. Get the full timeline:

Most recent: Clinical Trial Update: To Evaluate the Efficacy and Safety of GT20029 Solution in the Treatment of Androgenetic Alopecia (AGA) in Chinese Adult Males [Phase 2]

See pricing